Citation Impact

Citing Papers

Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
Melatonin attenuates D‐galactose‐induced memory impairment, neuroinflammation and neurodegeneration via RAGE/NFKB/JNK signaling pathway in aging mouse model
2014 Standout
Melatonin as a radioprotective agent: a review
2004
Neurophysiological characterization of parkinsonian syndromes
2000
Clinical conditions altering copper metabolism in humans
1998
Parkinson disease
2017 Standout
Pharmacokinetics of melatonin in human sexual maturation.
1996
The cholinergic hypothesis of Alzheimer's disease: a review of progress
1999 Standout
Allodynia after lateral-medullary (Wallenberg) infarct. A PET study
1998
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
2009 Standout
Neuroimaging in Parkinson disease: from research setting to clinical practice
2014
Resumption of high‐dose methotrexate after acute kidney injury and glucarpidase use in pediatric oncology patients
2012
Copper toxicity, oxidative stress, and antioxidant nutrients
2003 Standout
The Physiology and Pharmacology of Melatonin in Humans
1998
Parkinson's disease: clinical features and diagnosis
2008 Standout
Staging of brain pathology related to sporadic Parkinson’s disease
2002 Standout
Effect of inhibiting melatonin biosynthesis on spatial memory retention and tau phosphorylation in rat
2004
Overdependence on degraded gist memory in Alzheimer's disease.
2006 Standout
In vivo imaging of synaptic function in the central nervous system
2009
Depressive symptoms in Parkinson's disease are related to reduced [123I]FP-CIT binding in the caudate nucleus
2013
Epidemiology and risk factors for IBD
2015 Standout
Skin penetration enhancers
2013 Standout
Parkinson's disease
2015 Standout
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
Penetration enhancers
2003 Standout
Bioavailability of melatonin in humans after day-time administration of D7 melatonin
2000
Directed evolution of a magnetic resonance imaging contrast agent for noninvasive imaging of dopamine
2010 StandoutNobel
Comparison of the effect of fatty alcohols on the permeation of melatonin between porcine and human skin
2001
What we can do and what we cannot do with fMRI
2008 StandoutNature
Melatonin as a natural ally against oxidative stress: a physicochemical examination
2011 Standout
Non-motor features of Parkinson disease
2017 Standout
Inhibition and Brain Work
2007
The biopsychosocial approach to chronic pain: Scientific advances and future directions.
2007 Standout
Functional imaging of brain responses to pain. A review and meta-analysis (2000)
2000 Standout
Imaging biomarkers in Parkinson's disease
2011
Preparation of fluorine-18 labelled sugars and derivatives and their application as tracer for positron-emission-tomography
2000
Clinical manifestations of nutritional copper deficiency in infants and children
1998
One molecule, many derivatives: A never‐ending interaction of melatonin with reactive oxygen and nitrogen species?
2006 Standout
REVIEW: Gastrointestinal Melatonin: Localization, Function, and Clinical Relevance
2002 Standout
Biochemical Reactivity of Melatonin with Reactive Oxygen and Nitrogen Species: A Review of the Evidence
2001
Glucarpidase, Leucovorin, and Thymidine for High-Dose Methotrexate-Induced Renal Dysfunction: Clinical and Pharmacologic Factors Affecting Outcome
2010
Fluorine in medicinal chemistry
2007 Standout
Cognitive Dysfunction in Parkinson’s Disease: The Role of Frontostriatal Circuitry
2004
Mild affective symptoms in de novo Parkinson's disease patients: relationship with dopaminergic dysfunction
2012
Practice parameter: Management of dementia (an evidence-based review) [RETIRED]
2001 Standout
PET Studies of Cerebral Levodopa Metabolism: A Review of Clinical Findings and Modeling Approaches
2009
Sleep and inflammatory bowel disease: exploring the relationship between sleep disturbances and inflammation.
2013
Cognitive Impairments in Early Parkinson's Disease Are Accompanied by Reductions in Activity in Frontostriatal Neural Circuitry
2003
The Timing of Normal Puberty and the Age Limits of Sexual Precocity: Variations around the World, Secular Trends, and Changes after Migration
2003 Standout
Olfactory Hypersensitivity in Migraineurs: A H215O-PET Study
2008
The Metabolic Substrates of Bradykinesia and Tremor in Uncomplicated Parkinson's Disease
2002
Applications of Clinical Dopamine Imaging
2006
Invited Review: Oxidation of Biological Systems: Oxidative Stress Phenomena, Antioxidants, Redox Reactions, and Methods for Their Quantification
2002 Standout
Applications of Fluorine in Medicinal Chemistry
2015 Standout
ESPGHAN and ESPEN Guidelines Paediatric Parenteral Nutrition ‐ Annex: List of Products
2005 Standout
Preventing and Managing Toxicities of High-Dose Methotrexate
2016 Standout

Works of G. Galy being referenced

Effects of GABAA receptors activation on brain glucose metabolism in normal subjects and temporal lobe epilepsy (TLE) patients. A positron emission tomography (PET) study Part II: The focal hypometabolism is reactive to GABAA agonist administration in TLE
1994
The relation of putamen and caudate nucleus 18F-Dopa uptake to motor and cognitive performances in Parkinson’s disease
1999
Severe acute toxicity associated with high-dose methotrexate (MTX) therapy: use of therapeutic drug monitoring and test-dose to guide carboxypeptidase G2 rescue and MTX continuation
2006
Effects of GABAA receptors activation on brain glucose metabolism in normal subjects and temporal lobe epilepsy (TLE) patients. A positron emission tomography (PET) study Part I: Brain glucose metabolism is increased after GABAA receptors activation
1994
Pharmacokinetics of melatonin in man after intravenous infusion and bolus injection
1990
Relief of akinesia by apomorphine and cerebral metabolic changes in parkinson's disease
1993
Serum Copper and Zinc Concentration in Premature and Small-For-Date Infants
1980
Identification of 2-chloro-2-deoxyglucose (2-CIDG) and d-glucose as impurities formed in the synthesis of 2-18F]Fluoro-2-deoxyglucose (2-18FDG)
1994
Rankless by CCL
2026